The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Community-associated Clostridium difficile infection and antibiotics: a meta-analysis
Abstract
OBJECTIVES: Antibiotic exposure is the most important risk factor for Clostridium difficile infection (CDI). Most evaluations of antimicrobial risk factors have been conducted in healthcare settings. The objective of this meta-analysis was to evaluate the association between antibiotic exposure and community-associated CDI (CA-CDI) (i.e. symptom onset in the community with no healthcare facility admission within 12 weeks) and to determine the classes of antibiotics posing the greatest risk. METHODS: We searched four electronic databases for subject headings and text words related to CA-CDI and antibiotics. Studies that investigated the risk of CA-CDI associated with antibiotic usage were considered eligible. Data from the identified studies were combined using a random-effects model and ORs were calculated. RESULTS: Of 910 citations identified, eight studies (n = 30 184 patients) met our inclusion criteria. Antibiotic exposure was associated with an increased risk of CA-CDI (OR 6.91, 95% CI 4.17-11.44, I(2) = 95%). The risk was greatest with clindamycin (OR 20.43, 95% CI 8.50-49.09) followed by fluoroquinolones (OR 5.65, 95% CI 4.38-7.28), cephalosporins (OR 4.47, 95% CI 1.60-12.50), penicillins (OR 3.25, 95% CI 1.89-5.57), macrolides (OR 2.55, 95% CI 1.91-3.39) and sulphonamides/trimethoprim (OR 1.84, 95% CI 1.48-2.29). Tetracyclines were not associated with an increased CDI risk (OR 0.91, 95% CI 0.57-1.45). CONCLUSIONS: Antibiotic exposure was an important risk factor for CA-CDI, but the risk was different amongst different antibiotic classes. The risk was greatest with clindamycin followed by fluoroquinolones and cephalosporins, whereas tetracyclines were not associated with an increased risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
(2014) · Medical Entomology and Zoology · Cited by 17,633
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,178
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Davies, H. T. O., Crombie, I. K., & Tavakoli, M. (1998) · BMJ · doi:10.1136/bmj.316.7136.989 · Cited by 984
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Stevens, V., Dumyati, G., Fine, L. S., Fisher, S. G., & van Wijngaarden, E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir301 · Cited by 446
A case-control study of community-associated Clostridium difficile infection
Wilcox, M. H., Mooney, L., Bendall, R., Settle, C. D., & Fawley, W. N. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn163 · Cited by 372
Including Non‐Randomized Studies
Reeves, B. C., Deeks, J. J., Higgins, J. P., & Wells, G. A. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch13 · Cited by 288
Epidemiology of Community-Acquired Clostridium difficile-Associated Diarrhea
Hirschhorn, L. R., Trnka, Y., Onderdonk, A., Lee, M.-L. T., & Platt, R. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.127 · Cited by 237
Dial, S. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060284 · Cited by 218
Kutty, P. K., Woods, C. W., Sena, A. C., Benoit, S. R., Naggie, S., Frederick, J., Evans, S., Engel, J., & McDonald, L. C. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1602.090953 · Cited by 207
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection
Dial, S., Kezouh, A., Dascal, A., Barkun, A., & Suissa, S. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071812 · Cited by 166
Kuntz, J. L., Chrischilles, E. A., Pendergast, J. F., Herwaldt, L. A., & Polgreen, P. M. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-194 · Cited by 161
Surveillance for community-associated clostridium difficile--Connecticut, 2006
(2008) · PsycEXTRA Dataset · doi:10.1037/e458052008-003 · Cited by 120
McFarland, L. V., Clarridge, J. E., Beneda, H., & Raugi, G. J. (2007) · Clinical Infectious Diseases · doi:10.1086/522187 · Cited by 111
Bauer, M. P., Veenendaal, D., Verhoef, L., Bloembergen, P., van Dissel, J. T., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02853.x · Cited by 100
Naggie, S., Miller, B. A., Zuzak, K. B., Pence, B. W., Mayo, A., Nicholson, B. P., Kutty, P. K., McDonald, L. C., & Woods, C. W. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.10.013 · Cited by 96
Palmore, T. N., Sohn, S., Malak, S. F., Eagan, J. A., & Sepkowitz, K. A. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502602 · Cited by 93
Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting
Levy, D. G., Stergachis, A. S., McFarland, L. V., Vorst, K. V., Graham, D. J., Johnson, E. S., Park, B., Shatin, D., Clause, J. C., & Elmer, G. W. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)87980-1 · Cited by 87
Community-associatedClostridium difficileInfections, Monroe County, New York, USA
Dumyati, G. K., Stevens, V. W., Hannett, G. E., Thompson, A. D., Long, C., MacCannell, D., & Limbago, B. M. (2012) · Emerging infectious diseases · doi:10.3201/eid1803.102023 · Cited by 74
Does Doxycycline Protect Against Development of Clostridium difficile Infection?
Doernberg, S. B., Winston, L. G., Deck, D. H., & Chambers, H. F. “. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis457 · Cited by 60
Antibiotic-associated colitis.
Stergachis, A. S., Perera, D. R., Schnell, M. M., et al. (1984) · PubMed · Cited by 22
Cited by
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Probiotics in Medicine: A Long Debate
Stavropoulou, E., & Bezirtzoglou, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02192 · Cited by 282
Hospitalization type and subsequent severe sepsis
Prescott, H. C., Dickson, R. P., Rogers, M. A. M., Langa, K. M., & Iwashyna, T. J. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0483oc · Cited by 181
Pouwels, K. B., Hopkins, S., Llewelyn, M. J., Walker, A. S., McNulty, C. A., & Robotham, J. V. (2019) · BMJ · doi:10.1136/bmj.l440 · Cited by 126
The role of gut microbiota in Clostridium difficile infection
Samarkos, M., Mastrogianni, E., & Kampouropoulou, O. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.006 · Cited by 75
Metadata
- Authors
- Deshpande, A., Pasupuleti, V., Thota, P., Pant, C., Rolston, D. D. K., Sferra, T. J., Hernandez, A. V., & Donskey, C. J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-04-25
- Volume
- 68
- Issue
- 9
- Pages
- 1951-1961
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2134091331
- Cited by
- 404
- References
- 32
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.